<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2022</volume><submitter>Li X</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To systematically assess the clinical efficacy of the &lt;i>Jie Yu Wan&lt;/i> (JYW) formula in treating generalized anxiety disorder (GAD).&lt;h4>Methods&lt;/h4>A multicenter, prospective, double-blind, double-dummy, randomized controlled trial (RCT) was conducted at four hospitals in China. A total of one hundred thirty-three patients with GAD were enrolled from 2017 to 2019. This study aimed to evaluate the effects of a Traditional Chinese Medicine (TCM) JYW formula on GAD at eight weeks, with the use of Buspirone as the comparator. A stepwise dosing protocol was used (JYW: high dose 24 g/day, low dose 12 g/day; Buspirone: high dose 30 mg/day, low dose 15 mg/day) and the dose was adjusted depending on whether the treatment response of Hamilton Anxiety Scale (HAMA) score was less th</pubmed_abstract><journal>Evidence-based complementary and alternative medicine : eCAM</journal><pagination>9951693</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9012658</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effects of Jie Yu Wan on Generalized Anxiety Disorder: A Randomized Clinical Trial.</pubmed_title><pmcid>PMC9012658</pmcid><pubmed_authors>Ma R</pubmed_authors><pubmed_authors>Duan N</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Zhao A</pubmed_authors><pubmed_authors>Wei D</pubmed_authors><pubmed_authors>Zheng S</pubmed_authors><pubmed_authors>Jia H</pubmed_authors><pubmed_authors>Zhu H</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Ding Y</pubmed_authors><pubmed_authors>Guo H</pubmed_authors><pubmed_authors>Jia Y</pubmed_authors><pubmed_authors>Feng S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effects of Jie Yu Wan on Generalized Anxiety Disorder: A Randomized Clinical Trial.</name><description>&lt;h4>Objective&lt;/h4>To systematically assess the clinical efficacy of the &lt;i>Jie Yu Wan&lt;/i> (JYW) formula in treating generalized anxiety disorder (GAD).&lt;h4>Methods&lt;/h4>A multicenter, prospective, double-blind, double-dummy, randomized controlled trial (RCT) was conducted at four hospitals in China. A total of one hundred thirty-three patients with GAD were enrolled from 2017 to 2019. This study aimed to evaluate the effects of a Traditional Chinese Medicine (TCM) JYW formula on GAD at eight weeks, with the use of Buspirone as the comparator. A stepwise dosing protocol was used (JYW: high dose 24 g/day, low dose 12 g/day; Buspirone: high dose 30 mg/day, low dose 15 mg/day) and the dose was adjusted depending on whether the treatment response of Hamilton Anxiety Scale (HAMA) score was less th</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-19T00:43:07.841Z</modification><creation>2025-04-07T11:44:45.254Z</creation></dates><accession>S-EPMC9012658</accession><cross_references><pubmed>35432560</pubmed><doi>10.1155/2022/9951693</doi></cross_references></HashMap>